Application of nitric oxide in drug discovery and development

Expert Opinion on Drug Discovery

Volumn 6, Issue 11, 2011, Pages 1139-1154

  Bryan, Nathan S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

guanylyl cyclase; medicine; nitrate; nitric oxide; nitrite; nitrosothiols; supplements

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE DONOR;

CARDIOVASCULAR DISEASE; DIET; DIET SUPPLEMENTATION; DRUG INDICATION; DRUG INDUSTRY; DRUG RESEARCH; DRUG SYNTHESIS; ERECTILE DYSFUNCTION; HUMAN; INFLAMMATION; METABOLIC DISORDER; NONHUMAN; NUTRITION; PRIORITY JOURNAL; REVIEW;

EID: 80755189296     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2011.613933     Document Type: Review

References (133)

1. Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985;6:7738-42 (Pubitemid 16204424)
2. Hibbs JB Jr, Taintor RR, Vavrin Z. Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987;235:473-6 (Pubitemid 17009584)
3. Arnold WP, Mittal CK, Katsuki S, et al. Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA 1977;74:3203-7
4. Ignarro LJ, Buga GM, Wood KS, et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9
5. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetycholine. Nature 1980;288:373-6 (Pubitemid 11169009)
6. Garthwaite J, Charles SL, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 1988;336:385-8
7. Moncada S, Palmer RMJ, Higgs A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42
8. Koshland DE Jr. The molecule of the year. Science 1992;258:1861 (Pubitemid 23026719)
9. Abrams J. Beneficial actions of nitrates in cardiovascular disease. Am J Cardiol 1996;77:31C-7C
10. Nakamura Y, Moss AJ, Brown MW, et al. Long-term nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group. Am Heart J 1999;138:577-85 (Pubitemid 29428783)
11. Kanamasa K, Hayashi T, Kimura A, et al. Long-term, continuous treatment with both oral and transdermal nitrates increases cardiac events in healed myocardial infarction patients. Angiology 2002;53:399-408 (Pubitemid 34787651)
12. Bloch KD, Steinbicker A, Lohmeyer L, et al. Inhaled nitric oxide. In: Bryan NS, Loscalzo J. editors. Nitrite and nitrate in human health and disease. Springer Humana Press; New York; 2011. p. 187-206
13. Jain KK. Nitric oxide: therapeutics, markets and companies. Jain PharmaBiotech; Basel Switzerland: 2010
14. Katsuki S, Arnold W, Mittal C, Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 1977;3:23-35 (Pubitemid 8078230)
15. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12 (Pubitemid 24015045)
16. Marletta MA, Yoon PS, Iyengar R, et al. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is anintermediate. Biochemistry 1988;27:8706-11 (Pubitemid 19008186)
17. Liu Q, Gross SS. Binding sites of nitric oxide synthases. Methods Enzymol 1996;268:311-24 (Pubitemid 26286373)
18. Abu-Soud HM, Yoho LL, Stuehr DJ. Calmodulin controls neuronal nitric-oxide synthase by a dual mechanism. J Biol Chem 1994;269:32047-50
19. Abu-Soud HM, Stuehr DJ. Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc Natl Acad Sci USA 1993;90:10769-72 (Pubitemid 23347124)
20. Vasquez-Vivar J, Kalyanaraman B, Martasek P. The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free Radic Res 2003;37:121-7 (Pubitemid 36124338)
21. Liu L, Hausladen A, Zeng M, et al. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 2001;410:490-4
22. Friedman A, Friedman J. New biomaterials for the sustained release of nitric oxide: past, present and future. Expert Opin Drug Deliv 2009;6:1113-22
23. Stevens EV, Carpenter AW, Shin JH, et al. Nitric oxide-releasing silica nanoparticle inhibition of ovarian cancer cell growth. Mol Pharm 2010;7:775-85
24. Young JJ. Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systems. Rev Cardiovasc Med 2007;8(Suppl 1):S3-10 (Pubitemid 46481994)
25. Hetrick EM, Schoenfisch MH. Reducing implant-related infections: active release strategies. Chem Soc Rev 2006;35:780-9 (Pubitemid 44286273)
26. Zaher C, Goldberg GA, Kadlubek P. Estimating angina prevalence in a managed care population. Am J Manag Care 2004;10:S339-46
27. Leesar MA, Stoddard MF, Dawn B, et al. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 2001;103:2935-41 (Pubitemid 32578131)
28. Higa M, Takasu N, Tamanaha T, et al. Nitroglycerin spray rapidly improves pain in a patient with chronic painful diabetic neuropathy. Diabet Med 2004;21:1053-4 (Pubitemid 39215332)
29. Lindsey I, Jones OM, Cunningham C, Mortensen NJ. Chronic anal fissure. Br J Surg 2004;91:270-9 (Pubitemid 38379655)
30. Baxter K, Howden BO, Jablonski P. Heart preservation with celsior solution improved by the addition of nitroglycerine. Transplantation 2001;71:1380-4 (Pubitemid 32507108)
31. Yasuda H, Yamaya M, Nakayama K, et al. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer. J Clin Oncol 2006;24:688-94 (Pubitemid 46630435)
32. Daiber A, Munzel T, Gori T. Organic nitrates and nitrate tolerance-state of the art and future developments. Adv Pharmacol 2010;60:177-227
33. Hebert D, Xiang J-X, Lam JYT. Persistent inhibition of platelets during continuous nitroglycerin therapy despite hemodynamic tolerance. Circulation 1997;95:1308-13 (Pubitemid 27097845)
34. Fung HL. Biochemical mechanism of nitroglycerin action and tolerance: is this old mystery solved? Annu Rev Pharmacol Toxicol 2004;44:67-85
35. Feelisch M, Noack E, Schroder H. Explanation of the discrepancy between the degree of organic nitrate decomposition, nitrite formation and guanylate cyclase stimulation. Eur Heart J 1988;9(Suppl A):57-62
36. Needleman P, Lang S, Johnson EM Jr. Organic nitrates: relationship between biotransformation and rational angina pectoris therapy. J Pharmacol Exp Ther 1972;181:489-97
37. Fung HL, Bauer JA. Mechanisms of nitrate tolerance. Cardiovasc Drugs Ther 1994;8:489-99 (Pubitemid 24239716)
38. Chen Z, Foster MW, Zhang J, et al. An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci USA 2005;102:12159-64 (Pubitemid 41291145)
39. Munzel T, Sayegh H, Freeman BA, et al. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 1995;95:187-94
40. Pi X, Yan C, Kim D, et al. Differential expression of genes from nitrate-tolerant rat aorta. J Vasc Res 2002;39:304-10 (Pubitemid 34983861)
41. Packer M, Lee WH, Kessler PD, et al. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 1987;317:799-804 (Pubitemid 17136471)
42. Bassenge E, Fink N, Skatchkov M, Fink B. Dietary supplement with vitamin C prevents nitrate tolerance. J Clin Invest 1998;102:67-71 (Pubitemid 28323831)
43. Watanabe H, Kakihana M, Ohtsuka S, Sugishita Y. Randomized, double-blind, placebo-controlled study of supplemental vitamin E on attenuation of the development of nitrate tolerance. J Cardiol 1998;31:173-81 (Pubitemid 28182575)
44. Gori T, Burstein JM, Ahmed S, et al. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study. Circulation 2001;104:1119-23 (Pubitemid 32830394)
45. Parker JO, Parker JD, Caldwell RW, et al. The effect of supplemental L-arginine on tolerance development during continuous transdermal nitroglycerin therapy. J Am Coll Cardiol 2002;39:1199-203 (Pubitemid 34267425)
46. Watanabe H, Kakihana M, Ohtsuka S, Sugishita Y. Preventive effects of carvedilol on nitrate tolerance-a randomized, double-blind, placebo-controlled comparative study between carvedilol and arotinolol. J Am Coll Cardiol 1998;32:1201-6 (Pubitemid 28522374)
47. Bauer JA, Fung HL. Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure. Circulation 1991;84:35-9
48. Munzel T, Li H, Mollnau H, et al. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability [In Process Citation]. Circ Res 2000;86:E7-12
49. Wang EQ, Lee WI, Fung HL. Lack of critical involvement of endothelial nitric oxide synthase in vascular nitrate tolerance in mice. Br J Pharmacol 2002;135:299-302 (Pubitemid 34151161)
50. Nakamura Y, Moss AJ, Brown MW, et al. Long-term nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale postinfarction studies. Am Heart J 1999;138:577-85 (Pubitemid 29428783)
51. Daiber A, Oelze M, Wenzel P, et al. Nitrate tolerance as a model of vascular dysfunction: roles for mitochondrial aldehyde dehydrogenase and mitochondrial oxidative stress. Pharmacol Rep 2009;61:33-48
52. Keefer LK. Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates. Annu Rev Pharmacol Toxicol 2003;43:585-607 (Pubitemid 37372654)
53. Pavlos CM, Xu H, Toscano JP. Controlled photochemical release of nitric oxide from O2-substituted diazeniumdiolates. Free Radic Biol Med 2004;37:745-52 (Pubitemid 39078546)
54. Fiorucci S, Antonelli E, Burgaud JL, Morelli A. Nitric oxide-releasing NSAIDs: a review of their current status. Drug Saf 2001;24:801-11 (Pubitemid 32937972)
55. Wallace JL, Del Soldato P. The therapeutic potential of NO-NSAIDs. Fundam Clin Pharmacol 2003;17:11-20 (Pubitemid 36241449)
56. White WB, Schnitzer TJ, Fleming R, et al. Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis. Am J Cardiol 2009;104:840-5
57. McDonald LJ, Murad F. Nitric oxide and cyclic GMP signaling. Proc Soc Exp Biol Med Soc Exp Biol Med 1996;211:1-6
58. Lucas KA, Pitari GM, Kazerounian S, et al. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 2000;52:375-414
59. Biel M, Seeliger M, Pfeifer A, et al. Selective loss of cone function in mice lacking the cyclic nucleotide-gated channel CNG3. Proc Natl Acad Sci USA 1999;96:7553-7 (Pubitemid 29299700)
60. Boolell M, Allen MJ, Ballard SA, et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996;8:47-52
61. Lee YC, Martin E, Murad F. Human recombinant soluble guanylyl cyclase: expression, purification, and regulation. Proc Natl Acad Sci USA 2000;97:10763-8
62. Evgenov OV, Pacher P, Schmidt PM, et al. NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 2006;5:755-68 (Pubitemid 44323702)
63. Martin E, Lee YC, Murad F. YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components. Proc Natl Acad Sci USA 2001;98:12938-42 (Pubitemid 33051298)
64. Bryan NS, Bian K, Murad F. Discovery of the nitric oxide signaling pathway and targets for drug development. Front Biosci 2009;14:1-18
65. Conti M. Phosphodiesterases and cyclic nucleotide signaling in endocrine cells. Mol Endocrinol 2000;14:1317-27
66. Stamler JS, Simon DI, Osborne JA, et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992;89:444-8
67. Stamler JS, Lamas S, Fang FC. Nitrosylation. The prototypic redox-based signaling mechanism. Cell 2001;106:675-83 (Pubitemid 32900659)
68. Ignarro LJ, Lippton H, Edwards JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981;218:739-49 (Pubitemid 11005147)
69. Gaston B, Reilly J, Drazen JM, et al. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA 1993;90:10957-61 (Pubitemid 23354347)
70. Simon DI, Stamler JS, Jaraki O, et al. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler Thromb 1993;13:791-9 (Pubitemid 23164681)
71. Zhang Y, Hogg N. S-nitrosothiols: cellular formation and transport. Free Radic Biol Med 2005;38:831-8 (Pubitemid 40321074)
72. Zhang Y, Hogg N. The mechanism of transmembrane S-nitrosothiol transport. Proc Natl Acad Sci USA 2004;101:7891-6 (Pubitemid 38698024)
73. Stamler JS, Simon DI, Osborne JA, et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992;89:444-8
74. Foster MW, McMahon TJ, Stamler JS. S-nitrosylation in health and disease. Trends Mol Med 2003;9:160-8 (Pubitemid 36626705)
75. Heiss C, Lauer T, Dejam A, et al. Plasma nitroso compounds are decreased in patients with endothelial dysfunction. J Am Coll Cardiol 2006;47:573-9 (Pubitemid 43170846)
76. Lane P, Hao G, Gross SS. S-nitrosylation is emerging as a specific and fundamental posttranslational protein modification: head-to-head comparison with O-phosphorylation. Sci STKE 2001;2001:RE1
77. Hess DT, Matsumoto A, Kim SO, et al. Protein S-nitrosylation: purview and parameters. Nat Rev 2005;6:150-66 (Pubitemid 40215810)
78. Hara MR, Agrawal N, Kim SF, et al. S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 2005;7:665-74 (Pubitemid 40975747)
79. Whalen EJ, Foster MW, Matsumoto A, et al. Regulation of beta-Adrenergic receptor signaling by S-Nitrosylation of G-Protein-Coupled Receptor Kinase 2. Cell 2007;129:511-22 (Pubitemid 46660966)
80. Kelleher ZT, Matsumoto A, Stamler JS, Marshall HE. NOS2 regulation of NF-kappaB by S-nitrosylation of p65. J Biol Chem 2007;282:30667-72 (Pubitemid 350035227)
81. Kashiba-Iwatsuki M, Kitoh K, Kasahara E, et al. Ascorbic acid and reducing agents regulate the fates and functions of S-nitrosothiols. J Biochem 1997;122:1208-14 (Pubitemid 28019987)
82. Dicks AP, Williams DL. Generation of nitric oxide from S-nitrosothiols using protein-bound Cu2+ sources. Chem Biol 1996;3:655-9 (Pubitemid 26351774)
83. Gow AJ, Buerk DG, Ischiropoulos H. A novel reaction mechanism for the formation of S-nitrosothiol in vivo. J Biol Chem 1997;272:2841-5 (Pubitemid 27053331)
84. Inoue K, Akaike T, Miyamoto Y, et al. Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J Biol Chem 1999;274:27069-75
85. Liu L, Yan Y, Zeng M, et al. Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 2004;116:617-28 (Pubitemid 38264436)
86. Que LG, Liu L, Yan Y, et al. Protection from experimental asthma by an endogenous bronchodilator. Science 2005;308:1618-21 (Pubitemid 40807509)
87. Sanghani PC, Davis WI, Fears SL, et al. Kinetic and cellular characterization of novel inhibitors of S-nitrosoglutathione reductase. J Biol Chem 2009;284:24354-62
88. Bryan NS, Fernandez BO, Bauer SM, et al. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol 2005;1:290-7
89. Zweier JL, Wang P, Samouilov A, Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nat Med 1995;1:804-9
90. Lundberg JO, Weitzberg E, Lundberg JM, Alving K. Intragastric nitric oxide production in humans: measurements in expelled air. Gut 1994;35:1543-6 (Pubitemid 24339249)
91. Benjamin N, O'Driscoll F, Dougall H, et al. Stomach NO synthesis. Nature 1994;368:502
92. Kleinbongard P, Dejam A, Lauer T, et al. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 2003;35:790-6 (Pubitemid 37329482)
93. Angelo M, Singel DJ, Stamler JS. An S-nitrosothiol (SNO) synthase function of hemoglobin that utilizes nitrite as a substrate. Proc Natl Acad Sci USA 2006;103:8366-71 (Pubitemid 43838461)
94. Tannenbaum SR, Sinskey AJ, Weisman M, Bishop W. Nitrite in human saliva. Its possible relationship to nitrosamine formation. J Natl Cancer Inst 1974;53:79-84
95. van Maanen JM, van Geel AA, Kleinjans JC. Modulation of nitrate-nitrite conversion in the oral cavity. Cancer Detect Prev 1996;20:590-6 (Pubitemid 27017069)
96. Duncan C, Dougall H, Johnston P, et al. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med 1995;1:546-51
97. Lundberg JO, Govoni M. Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic Biol Med 2004;37:395-400 (Pubitemid 38834005)
98. Spiegelhalder B, Eisenbrand G, Preussmann R. Influence of dietary nitrate on nitrite content of human saliva: possible relevance to in vivo formation of N-nitroso compounds. Food Cosmet Toxicol 1976;14:545-8 (Pubitemid 8050597)
99. Lundberg JO, Weitzberg E, Cole JA, Benjamin N. Nitrate, bacteria and human health. Nat Rev Microbiol 2004;2:593-602
100. Feelisch M, Fernandez BO, Bryan NS, et al. Tissue Processing of Nitrite in Hypoxia: An Intricate Interplay of Nitric Oxide-Generating and -Scavenging Systems. J Biol Chem 2008;283:33927-34
101. Bryan NS, Rassaf T, Maloney RE, et al. Cellular targets and mechanisms of Nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc Natl Acad Sci USA 2004;101:4308-13 (Pubitemid 38405925)
102. Zweier JL, Wang P, Samouilov A, Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nat Med 1995;1:804-9
103. Bryan NS. Nitrite in nitric oxide biology: cause or consequence? A systems-based review. Free Radic Biol Med 2006;41:691-701 (Pubitemid 44163410)
104. Walters CL, Casselden RJ, Taylor AM. Nitrite metabolism by skeletal muscle mitochondria in relation to haem pigments. Biochim Biophys Acta 1967;143:310-18
105. Kozlov AV, Staniek K, Nohl H. Nitrite reductase activity is a novel function of mammalian mitochondria. FEBS Lett 1999;454:127-30 (Pubitemid 29296938)
106. Cosby K, Partovi KS, Crawford JH, et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 2003;9:1498-505 (Pubitemid 38004777)
107. Li H, Samouilov A, Liu X, Zweier JL. Characterization of the effects of oxygen on xanthine oxidase-mediated nitric oxide formation. J Biol Chem 2004;279:16939-46 (Pubitemid 38560446)
108. Webb A, Bond R, McLean P, et al. Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc Natl Acad Sci USA 2004;101:13683-8 (Pubitemid 39238463)
109. Bryan NS, Calvert JW, Elrod JW, et al. Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc Natl Acad Sci USA 2007;104:19144-9
110. Duranski MR, Greer JJ, Dejam A, et al. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 2005;115:1232-40 (Pubitemid 40629041)
111. Pluta RM, Dejam A, Grimes G, et al. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. JAMA 2005;293:1477-84 (Pubitemid 40393292)
112. Hunter CJ, Dejam A, Blood AB, et al. Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator. Nat Med 2004;10:1122-7 (Pubitemid 39424875)
113. Hardwick JB, Tucker AT, Wilks M, et al. A novel method for the delivery of nitric oxide therapy to the skin of human subjects using a semi-permeable membrane. Clin Sci (Lond) 2001;100:395-400 (Pubitemid 32324337)
114. Bjorne HH, Petersson J, Phillipson M, et al. Nitrite in saliva increases gastric mucosal blood flow and mucus thickness. J Clin Invest 2004;113:106-14 (Pubitemid 38541637)
115. Tsuchiya K, Kanematsu Y, Yoshizumi M, et al. Nitrite is an alternative source of NO in vivo. Am J Physiol 2005;288:H2163-70 (Pubitemid 40604101)
116. Kleinbongard P, Dejam A, Lauer T, et al. Plasma nitrite concentrations reflect the degree of endothelial dysfunction in humans. Free Radic Biol Med 2006;40:295-302 (Pubitemid 43069353)
117. Larsen FJ, Ekblom B, Sahlin K, et al. Effects of dietary nitrate on blood pressure in healthy volunteers. N Engl J Med 2006;355:2792-3 (Pubitemid 46021534)
118. Webb AJ, Patel N, Loukogeorgakis S, et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 2008;51:784-90 (Pubitemid 351301536)
119. Shiva S, Sack MN, Greer JJ, et al. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med 2007;204:2089-102 (Pubitemid 47360871)
120. Cleeter MW, Cooper JM, Darley-Usmar VM, et al. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994;345:50-4 (Pubitemid 24154664)
121. Nisoli E, Clementi E, Paolucci C, et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003;299:896-9 (Pubitemid 36182449)
122. Brown GC, Cooper CE. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett 1994;356:295-8 (Pubitemid 24376992)
123. Erusalimsky JD, Moncada S. Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. Arterioscler Thromb Vasc Biol 2007;27:2524-31 (Pubitemid 350158901)
124. Taylor CT, Moncada S. Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia. Arterioscler Thromb Vasc Biol 2010;30:643-7
125. Nohl H, Staniek K, Sobhian B, et al. Mitochondria recycle nitrite back to the bioregulator nitric monoxide. Acta Biochim Pol 2000;47:913-21
126. Weitzberg E, Hezel M, Lundberg JO. Nitrate-nitrite-nitric oxide pathway: implications for anesthesiology and intensive care. Anesthesiology 2010;113:1460-75
127. Bryan NS, Loscalzo J. editors. Nitrite and nitrate in human health and disease. Humana Press; New York: 2011
128. Bryan NS. editor. Food, Nutrition and the nitric oxide pathway: biochemistry and bioactivity. DesTech Publishing; Lancaster, PA: 2009
129. DeNavas-Walt C, Proctor BD, Lee CH. Income, poverty and health insurance coverage in the United States. In: Commerce USDo. US Census Bureau; Washington, DC; 2006
130. Hord NG, Tang Y, Bryan NS. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am J Clin Nutr 2009;90:1-10
131. Hord NG, Ghannam JS, Garg HK, et al. Nitrate and nitrite content of human, formula, bovine and soy milks: implications for dietary nitrite and nitrate recommendations. Breastfeed Med 2010;In press
132. Zand J, Lanza F, Garg HK, Bryan NS. All-natural nitrite and nitrate containing dietary supplement promotes nitric oxide production and reduces triglycerides in humans. Nutr Res 2011;31:262-9
133. Lundberg JO, Gladwin MT, Ahluwalia A, et al. Nitrate and nitrite in biology, nutrition and therapeutics. Nat Chem Biol 2009;5:865-9